Market Update: Pfizer Inc (NYSE:PFE) – How Pfizer has shifted U.S. profits overseas for years

[Reuters] – Drugmaker Pfizer’s plans to take over Allergan have faced a political backlash in the United States over fears a deal would lead to the company shifting its headquarters and taxable profits . . . → Read More: Market Update: Pfizer Inc (NYSE:PFE) – How Pfizer has shifted U.S. profits overseas for years Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – Pfizer’s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap) Vaccines in Adole Market Update (NYSE:PFE): Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference Stock Update: Pfizer Inc (NYSE:PFE) – GSK sells two vaccines to Pfizer to ease competition concerns
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.